Workflow
I'm Not Kidding - These 2 Beaten Stocks Could Double
Seeking Alpha· 2025-06-16 11:30
Group 1 - The article emphasizes the universal desire among individuals to grow their net worth and create new income streams, regardless of personal characteristics [1] - iREIT on Alpha offers in-depth research on various investment vehicles including REITs, mREITs, Preferreds, BDCs, MLPs, and ETFs, highlighting its value proposition through 438 testimonials, most of which are 5 stars [1] Group 2 - There is a disclosure regarding a beneficial long position in the shares of ODFL, indicating a vested interest in the stock [2] - The article expresses personal opinions of the author and clarifies that no compensation is received for the article, aside from Seeking Alpha [2] Group 3 - Seeking Alpha provides a disclaimer that past performance does not guarantee future results and that no specific investment advice is being given [3] - The platform clarifies that its analysts are third-party authors, which may include both professional and individual investors who might not be licensed or certified [3]
TEGNA Announces Major Local News Expansion: Adding More than 100 Hours of New Daily Programming Across 50+ Markets
Globenewswire· 2025-06-16 11:30
Core Viewpoint - TEGNA Inc. is expanding its local news programming by launching live and on-demand newscasts from 7 to 9 a.m. daily in over 50 markets to meet the growing demand for local coverage on connected TV platforms [1][2][3] Group 1: Expansion of Local News Programming - The expansion will deliver over 100 hours of daily breaking news, weather, and traffic to more than 100 million viewers [2] - Stations in 35 markets will actively deliver live, local programming from 7 to 9 a.m. this summer, with over 50 markets expected to have this programming in the fall [4] Group 2: Audience Engagement and Advertiser Opportunities - The new programming allows audiences to watch live news produced by their trusted stations during a time when local coverage has been largely unavailable, enhancing viewer experience [3] - The content expansion is expected to create new opportunities for advertisers to reach audiences regardless of their viewing preferences [3] Group 3: Testing and Viewership Growth - TEGNA stations began testing the live digital news stream in the 7 a.m. time slot earlier this year, with some markets experiencing nearly a 50% month-over-month increase in viewership during severe weather or breaking news [3] Group 4: Accessing the New Programming - Viewers can access the local morning livestreams from 7-9 a.m. through the TEGNA station Plus app on various streaming devices or directly from local station websites [5] Group 5: Company Overview - TEGNA Inc. operates 64 television stations in 51 U.S. markets, reaching over 100 million people monthly across various platforms [6]
Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology
GlobeNewswire News Room· 2025-06-16 11:30
Core Insights - Emory University and Micron Biomedical have initiated the first clinical trial of a novel rotavirus vaccine, CC24, utilizing dissolvable microarray technology, marking a significant advancement in vaccine delivery methods [1][2][3] Company Insights - Micron Biomedical specializes in dissolvable microarray technology for drug and vaccine administration, aiming to enhance access and health outcomes globally through painless, needle-free self-administration [9] - The company has developed a unique needle-free technology that allows for rapid delivery of vaccines, reducing the need for cold chain logistics and producing no medical sharps waste [3][9] - Micron Biomedical collaborates with various organizations, including the CDC and the Gates Foundation, to advance its technology and improve vaccine accessibility [9] Industry Insights - Rotavirus remains a leading cause of childhood diarrheal deaths, particularly in low- and middle-income countries, where existing oral vaccines are less effective [2][4] - The trial aims to address the limitations of current oral rotavirus vaccines and improve vaccine uptake through innovative delivery methods [4][5] - The study will recruit 50 healthy adults aged 18 to 45, with data expected to inform future studies in children [6][7]
NFI subsidiary New Flyer signs a major contract with New Jersey Transit for up to 750 buses
Globenewswire· 2025-06-16 11:30
Core Viewpoint - NFI Group Inc. has secured a significant contract with New Jersey Transit Corporation for the purchase of up to 750 Xcelsior 60-foot clean-diesel transit buses, marking a major milestone in the company's history of clean-diesel bus procurements [2][3]. Group 1: Contract Details - The contract includes an initial firm order for 200 buses (400 equivalent units) with deliveries starting in 2026, and options for an additional 550 buses (1,100 equivalent units) [3]. - This order has been added to New Flyer's first-quarter 2025 backlog, indicating strong demand for clean-diesel solutions [3]. Group 2: Company Commitment and Partnership - NFI's subsidiary, New Flyer, emphasizes its long-standing partnership with NJ TRANSIT, which is based on trust, innovation, and performance [4]. - NJ TRANSIT operates a diverse fleet, including buses from the NFI family, and relies on a dedicated parts support program to maintain service efficiency [4]. Group 3: Impact on Regional Mobility - NJ TRANSIT provides over 225 million annual passenger trips and operates a fleet of over 3,500 vehicles, playing a crucial role in regional mobility [5]. - The new buses will replace aging vehicles, enhancing service reliability and efficiency across the transit system [5]. Group 4: Technological Advancements - The Xcelsior clean-diesel platform features ultra-low sulfur diesel fuel, next-generation engines, and advanced emissions control systems, designed for high-demand urban environments [6]. Group 5: Company Overview - NFI is a leading global bus manufacturer with a wide range of propulsion-agnostic bus and coach platforms, including electric models, and supports over 100,000 buses and coaches worldwide [9]. - New Flyer is recognized as North America's heavy-duty transit bus leader, actively supporting over 35,000 heavy-duty transit buses currently in service [10].
South Pacific Metals Announces Management Change
Newsfile· 2025-06-16 11:30
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2025) - South Pacific Metals Corp. (TSXV: SPMC) (OTCQB: SPMEF) (FSE: 6J00) ("SPMC" or "South Pacific Metals" or the "Company") announces that Ms. Cathy Fitzgerald will be stepping down as an officer and director of the Company, effective July 11, 2025.Cathy has played a pivotal role in the growth and strategic direction of South Pacific Metals. As President, her leadership and technical expertise have been instrumental in shaping the Company's explora ...
Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™
Globenewswire· 2025-06-16 11:20
Award-Winning DEXA Technology™ Continues to Redefine Patient-Matched Spinal Care Please click to view image CARLSBAD, CALIFORNIA, June 16, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spinal implant technology, is proud to announce that its DEXA-C™ system has now been successfully used in more than 1,500 cervical spine procedures across the United States. This milestone underscores the ongoing adoption and trusted per ...
Tariff Talks Advance, What Taiwan Semiconductor Can Deliver
MarketBeat· 2025-06-16 11:19
Taiwan Semiconductor Manufacturing TodayTSMTaiwan Semiconductor Manufacturing$211.07 -4.36 (-2.02%) 52-Week Range$133.57▼$226.40Dividend Yield1.12%P/E Ratio29.98Price Target$217.00Add to WatchlistAny investor who has been exposed to the United States technology sector has learned the meaning of volatility over the past few quarters, especially as President Trump's trade tariffs start to significantly impact the sector’s future expectations and forecasts. However, not all are doomed for this space.Get TSM a ...
Future of Unilever's Ice Cream Business: A Planned Demerger in 2025
GlobeNewswire News Room· 2025-06-16 11:17
Dublin, June 16, 2025 (GLOBE NEWSWIRE) -- The "Unilever Group in Snacks (World)" company profile has been added to ResearchAndMarkets.com's offering.Unilever ranks sixth in overall snacks sales globally, but is the clear leader in the ice cream category, accounting for a fifth of retail value sales worldwide. However, 2024 is expected to be the last one in which Unilever's ice cream business was included in the group's overall earnings figures, with a demerger of this division planned by the company by the ...
DoubleDown Interactive: Insider Sale Doesn't Change The Fundamentals, I'm Doubling Down
Seeking Alpha· 2025-06-16 11:15
Group 1 - DoubleDown Interactive (DDI) experienced a significant decline of 23.7% on June 12 following an insider selling shares at $8.50 each, raising questions about its investment potential [1] - Despite the recent drop, there is a belief that DDI remains a viable investment opportunity [1] Group 2 - The investment strategy focuses on GARP (growth at a reasonable price) stocks while also seeking opportunities in other areas [2] - The investment approach does not adhere to a specific time horizon, with positions held as long as the investment thesis remains valid [2] - The analyst has developed market-beating algorithms using Python to identify attractive investment opportunities [2]
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)
Prnewswire· 2025-06-16 11:15
Updated Phase 2 data evaluating ZYNLONTA® as a monotherapy demonstrate overall response rate (ORR) of 85% and complete response (CR) rate of 69% CR maintained in 17 of 18 patients who achieved CR, with longest duration of CR of 27 months from start of treatmentZYNLONTA was generally well tolerated and safety was consistent with known profile LAUSANNE, Switzerland, June 16, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjug ...